580 related articles for article (PubMed ID: 19293593)
1. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients.
Ng HY; Chen HC; Pan LL; Tsai YC; Hsu KT; Liao SC; Chuang FR; Chen JB; Lee CT
Nephron Clin Pract; 2009; 111(4):c247-52. PubMed ID: 19293593
[TBL] [Abstract][Full Text] [Related]
2. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency.
Miwa N; Akiba T; Kimata N; Hamaguchi Y; Arakawa Y; Tamura T; Nitta K; Tsuchiya K
Int J Lab Hematol; 2010 Apr; 32(2):248-55. PubMed ID: 19624802
[TBL] [Abstract][Full Text] [Related]
4. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
5. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
[TBL] [Abstract][Full Text] [Related]
6. Ret-Y a measure of reticulocyte size: a sensitive indicator of iron deficiency anemia.
Kickler TS; Borowitz MJ; Thompson RE; Charintranont N; Law R
Clin Lab Haematol; 2004 Dec; 26(6):423-7. PubMed ID: 15596002
[TBL] [Abstract][Full Text] [Related]
7. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.
Garzia M; Di Mario A; Ferraro E; Tazza L; Rossi E; Luciani G; Zini G
Lab Hematol; 2007; 13(1):6-11. PubMed ID: 17353176
[TBL] [Abstract][Full Text] [Related]
8. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
9. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
Schoorl M; Schoorl M; Nubé MJ; Bartels PC
Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
[TBL] [Abstract][Full Text] [Related]
10. [Measuring the content of reticulocyte hemoglobin (CHr) in predialysis chronic renal failure (CRF) patients].
Saito M; Tsuchiya K; Ando M; Akiba T; Nihei H
Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):430-8. PubMed ID: 14509218
[TBL] [Abstract][Full Text] [Related]
11. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
Daschner M; Mehls O; Schaefer F
Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
[TBL] [Abstract][Full Text] [Related]
12. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
Davidkova S; Prestidge TD; Reed PW; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of iron deficiency in patients undergoing hemodialysis.
Buttarello M; Pajola R; Novello E; Rebeschini M; Cantaro S; Oliosi F; Naso A; Plebani M
Am J Clin Pathol; 2010 Jun; 133(6):949-54. PubMed ID: 20472854
[TBL] [Abstract][Full Text] [Related]
14. Reticulocyte indices in patients with end stage renal disease on hemodialysis.
Bhandari S; Turney JH; Brownjohn AM; Norfolk D
J Nephrol; 1998; 11(2):78-82. PubMed ID: 9589378
[TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-dialysis stage and in patients on peritoneal dialysis].
Eguchi A; Tsuchiya K; Tsukada M; Nitta K
Nihon Jinzo Gakkai Shi; 2010; 52(2):132-40. PubMed ID: 20415234
[TBL] [Abstract][Full Text] [Related]
16. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
18. Innovative parameters RET-Y, sTfR, and sTfR-F index in patients with microcytic, hypochromic anemia--their special value for hemoglobinopathies.
Agorasti A; Trivellas T; Papadopoulos V; Konstantinidou D
Lab Hematol; 2007; 13(2):63-8. PubMed ID: 17573284
[TBL] [Abstract][Full Text] [Related]
19. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
20. The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia.
Buttarello M; Temporin V; Ceravolo R; Farina G; Bulian P
Am J Clin Pathol; 2004 Apr; 121(4):489-95. PubMed ID: 15080300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
